Trial
NCT00482066
Abatacept in ANCA Associated Vasculitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
Bristol-Myers Squibb
Condition
ANCA-associated Vasculitis
Intervention
Abatacept (Orencia)
Why stopped
Funders withdrew funding due to slow recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-29